The impact of recombinant human erythropoietin on exercise capacity in hemodialysis patients (Q38511231)

3 September 2017

1 reference

title

The impact of recombinant human erythropoietin on exercise capacity in hemodialysis patients (English)

1 reference

3 September 2017

1 reference

Painter P

1

1 reference

3 September 2017

Moore GE

series ordinal

2

1 reference

3 September 2017

language of work or name

1 reference

1 April 1994

1 reference

Advances in Chronic Kidney Disease

3 September 2017

1 reference

3 September 2017

1

1 reference

3 September 2017

55-65

1 reference

3 September 2017

1

1 reference

Exercise capacity in hemodialysis, CAPD, and renal transplant patients

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Determinants of VO2peak in patients with end-stage renal disease: on and off dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Feasibility and benefits of exercise training in patients on maintenance dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Exercise in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Factors limiting physical working capacity in predialytic uraemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Exercise tolerance changes following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Isokinetic muscle strength predicts maximum exercise tolerance in renal patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Uremic myopathy limits aerobic capacity in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Effects of exercise training during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Efficacy of exercise for end-stage renal disease patients immediately following high-efficiency hemodialysis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Working capacity is increased following recombinant human erythropoietin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Exercise in hemodialysis patients after treatment with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Improvement in exercise capacity after correction of anemia in patients with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Effect of acute and established anemia on O2 transport at rest, submaximal and maximal work

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Response to exercise after blood loss and reinfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Effect of induced erythrocythemia on hypoxia tolerance during physical exercise

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Dialysis myopathy. Report of 13 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Cell metabolism in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Light microscopic study of striated muscle in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Striated muscle ultrastructure in uremic patients and in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Plasma and muscle carnitine levels in haemodialysis patients with morphological-ultrastructural examination of muscle samples

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Evaluation of the effect of intravenous L-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

31P-magnetic resonance spectroscopy assessment of subnormal oxidative metabolism in skeletal muscle of renal failure patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

Skeletal muscle response to exercise training in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2812%2980022-7

7 January 2021

10.1016/S1073-4449(12)80022-7

Identifiers

DOI

0 references

1 reference